All data are based on the daily closing price as of September 6, 2024
t
Towa Pharmaceutical
4553.TSE
20.67 USD
0.02
+0.10%
Overview
Last close
20.67 usd
Market cap
1.02B usd
52 week high
21.01 usd
52 week low
11.94 usd
Target price
24.81 usd
Valuation
P/E
8.5836
Forward P/E
16.7785
Price/Sales
0.6154
Price/Book Value
0.9314
Enterprise Value
2.23B usd
EV/Revenue
1.3473
EV/EBITDA
11.7791
Key financials
Revenue TTM
1.66B usd
Gross Profit TTM
511.10M usd
EBITDA TTM
264.17M usd
Earnings per Share
2.42 usd
Dividend
0.42 usd
Total assets
2.81B usd
Net debt
1.11B usd
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.